{"id":"W2914777901","doi":"10.1200/jco.2019.37.4_suppl.422","title":"Real world eligibility for cabozantinib (C), regorafenib (Reg), and ramucirumab (Ram) in hepatocellular carcinoma (HCC) patients after sorafenib (S).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Regorafenib; Sorafenib; Hepatocellular carcinoma; Cabozantinib; Internal medicine; Ramucirumab; Clinical trial; Pazopanib; Generalizability theory; Oncology; Cancer; Hazard ratio; Confidence interval; Colorectal cancer; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001230232,0.000118,0.0002624344,0.0005783219,0.0004561261,0.0006273886,0.0003493237,0.0003121518,0.001576548],"category_scores_gemma":[0.002721888,0.0001235912,0.0002118114,0.0009405675,0.0004115186,0.0002403771,0.0003015846,0.0003226819,0.0002294704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002361284,"about_ca_system_score_gemma":0.002432272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06313494,"about_ca_topic_score_gemma":0.1530709,"domain_scores_codex":[0.9992257,0.0002307074,0.00009311301,0.0001183606,0.0001742872,0.0001578275],"domain_scores_gemma":[0.9975284,0.0005040811,0.001243402,0.00008691746,0.0002058481,0.0004314232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002683601,0.0001121887,0.9901465,0.00008512605,0.00004310951,0.0002240677,0.0001554036,0.0001982249,0.0003255043,0.00005706308,0.001148568,0.004820588],"study_design_scores_gemma":[0.0001326737,0.0003476961,0.9971553,0.00002523243,0.00003169555,0.0002776188,0.0002175172,0.0004380726,0.0001527485,0.00003155771,0.001178957,0.00001088849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963232,0.0003311014,0.00006877386,0.0001208223,0.000004971805,0.0001040382,0.00227632,0.000004874641,0.0007658893],"genre_scores_gemma":[0.9981396,0.00008734993,0.0001135805,0.00005213241,0.000006358464,0.0000599862,0.001371387,0.000001271707,0.0001683687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06313494,"threshold_uncertainty_score":0.1255349,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08459065596358865,"score_gpt":0.3700940577798194,"score_spread":0.2855034018162307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}